04:56:28 EDT Fri 17 May 2024
Enter Symbol
or Name
USA
CA



T:AVCN - AVICANNA INC. J - http://www.avicanna.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
AVCN - T  4.00.35·0.3610.00.35-0.015-4.1157.1471260.365  0.365  0.320.60  0.23May 16May 1415 min RT 2¢
TSX - T4.00.35·0.3610.00.35-0.015-4.195.729760.365  0.365  0.3250.60  0.23May 1615 min
NEO ATS - U 0.345-0.02-5.525.07210.35  0.35  0.33May 1615 min
Alpha - A 0.33-0.035-9.616.0520.355  0.355  0.33May 1615 min
Omega - O 0.345-0.02-5.51.5020.35  0.35  0.345May 1615 min
Pure - P 0.3650.602    Apr 1615 min
Chi-X - X 0.33-0.035-9.61.0010.33  0.33  0.33May 1615 min
CX2 - H 0.345-0.02-5.517.05140.36  0.36  0.32May 1615 min
CXD - D 0.3650.25    May 0315 min
TriAct - M 0.3650.23    Sep 03-2015 min

Recent Trades - Last 10 of 126
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-05-14 13:13C:AVCN0.33News ReleaseAvicanna talks Q1 2024 revenue, omits P&L
2024-05-13 19:32C:AVCN0.33SEDAR Interim MD & ASEDAR Interim MD & A
2024-05-13 19:26C:AVCN0.33SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-05-13 12:20C:AVCN0.33News ReleaseAvicanna completes RHO Phyto observational study
2024-04-18 17:02C:AVCN0.38News ReleaseAvicanna closes $2.12-million private placement
2024-04-10 13:35C:AVCN0.39News ReleaseAvicanna completes gel real-world evidence study
2024-04-02 11:30C:AVCN0.53News ReleaseAvicanna omits P&L from FY 2023 NR, talks revenue
2024-04-01 21:16C:AVCN0.53SEDAR Annual Information FormSEDAR Annual Information Form
2024-04-01 21:09C:AVCN0.53SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-04-01 21:09C:AVCN0.53SEDAR MD & ASEDAR MD & A
2024-03-27 12:30C:AVCN0.53News ReleaseAvicanna rolls out Rho Phyto Micro Drop 100
2024-03-26 11:31C:AVCN0.51News ReleaseAvicanna to release 2023 results April 1
2024-02-15 11:27C:AVCN0.45News ReleaseAvicanna forms research collaboration with EU company
2024-02-13 11:39C:AVCN0.40News ReleaseAvicanna receives Trunerox approval from INVIMA
2024-02-05 11:11C:AVCN0.32News ReleaseAvicanna to supply two products to multinational pharma
2024-01-30 12:05C:AVCN0.325News ReleaseAvicanna partner gets commercialization OK in Brazil
2023-12-04 17:03C:AVCN0.46News ReleaseAvicanna closes $888,127 private placement
2023-11-14 17:39C:AVCN0.425SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-14 17:37C:AVCN0.425SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-14 17:05C:AVCN0.425News ReleaseAvicanna omits P&L from Q3 NR, talks revenue